Stock Analysis
Cerebras Systems Inc. (CBRS)
NASDAQ: CBRS · AI Compute
Updated
Rated Watchlist, with a fair value of $135.85 against a last close of $127.21 (+6.8% implied upside). The shares reached the $125 to $135 range named on 1 October, but fair value fell with them to $135.85, so the margin of safety is not there and the watch price moves to $105 while OpenAI's funding and hardware questions stay open.
- Verdict
- Watchlist
- Fair Value
- $135.85
- Investment Score
- 60.2/100prev 56.8
Investment Scorecard
Composite score 60.2/100 (previous 56.8). Every factor is scored out of 10, ten always being the best outcome, including for risk.
| Factor | Score | Weight | Change | Basis |
|---|---|---|---|---|
| Business Quality | 6/10 | 16% | unchanged | Real differentiation; GAAP economics still distorted by warrants and SBC |
| Financial Strength | 7/10 | 16% | unchanged | About $7bn net cash against large lease and capex commitments |
| Competitive Advantage | 6/10 | 16% | -1 vs last report | Speed lead intact; hyperscaler in-house inference narrows the field |
| Management | 6/10 | 10% | unchanged | Guidance raised; heavy insider selling through the lock-up |
| Growth Potential | 8/10 | 16% | unchanged | $25.4bn backlog and a plan to triple 2027 revenue |
| Valuation | 5/10 | 16% | +3 vs last report | About 9x 2027 analyst revenue; price near weighted fair value |
| Risk (10 = lowest risk) | 3/10 | 10% | unchanged | Concentration, customer funding and commitments are correlated |
Recent Developments
| Date | Development | Impact |
|---|---|---|
| Lock-up release and insider sales About 19.4m shares became eligible on each of 30 Sep and 14 Oct; officers sold about $112m around the first wave and further Form 4s followed on 2, 6 and 7 Oct. Final release by 9 Nov. Reading: Supply overhang explains part of the fall but says nothing about the business. | Medium | |
| OpenAI Ultrafast tier hardware Reported, unconfirmed: SemiAnalysis said on 30 Sep that GPT-6.1 Sol Ultrafast runs on Nvidia GPUs. On 2 Oct Sam Altman called Cerebras a close partner with a deep engagement on speed, without naming the hardware. Reading: Still the central open question on concentration; carries no weight until either company answers it. | Medium | |
| Gimlet Labs and General Compute deals Gimlet: CS-4 systems totalling about 100 MW over one to two years. General Compute: multi-year deployment from Q1 2027. No values disclosed. Reading: Broadens 2027 demand; cannot move the scenarios without disclosed economics. | Medium | |
| AMD and AWS disaggregated inference AMD pairing expected in production in Q4 2026; AWS Bedrock in Q1 2027. No change in the period. Reading: Dated milestones to check at the next two reports. | Low |
Key Risks
| Risk | Probability | Severity | Comment |
|---|---|---|---|
| Lease and capital commitments | Moderate | High | More than 600 MW under contract by end-2027; first-half capex $549m. |
| Valuation compression | Moderate | High | About 9 times 2027 analyst revenue still prices strong conversion. |
| Hyperscaler in-house silicon | High | Medium | Maia 300 and Trainium compete for the same inference workloads. |
| Lock-up and insider supply | High | Medium | Releases through 9 November. |
| OpenAI workload migration | Low-moderate | Severe | Unconfirmed claim on the new Ultrafast tier; confirmation would hit the core thesis. |
| Customer concentration | Present | Severe | OpenAI anchors the backlog; G42 and MBZUAI supplied most of 2025 revenue. |
| OpenAI funding and pace | Moderate | Severe | Reported revenue run rate of about $50bn, not $70bn; commitment conversion depends on its capital. |
Scenario Analysis
| Case | Probability | Fair Value | Outlook |
|---|---|---|---|
| Bull | 25% | $205 | OpenAI and AWS ramp on time and neocloud deals scale; 2027 core revenue $3.4bn at 14x EV/sales. |
| Base | 45% | $144 | Revenue roughly triples with some friction; 2027 core revenue $2.85bn at 11x EV/sales. |
| Bear | 30% | $66 | OpenAI pace slips or workloads shift; 2027 core revenue $1.8bn at 6x EV/sales. |
The Case
Cerebras has a real speed advantage in inference, a $25.4bn backlog and about $7bn of net cash, and management plans to more than triple revenue in 2027. The price has fallen to the level once named as attractive, but counting the warrant shares, a lower multiple and a heavier bear case put fair value at $135.85, close to the price. The customer that anchors most of the backlog is reported to be smaller than its backers were told, and the hardware behind its newest fast tier is unconfirmed. The name becomes interesting at about $105, or sooner if third-quarter results show OpenAI billings accelerating.
Archived Reports
Beating The Bull keeps every past version of this report on file. Verdicts and numbers reflect what was known when each one was published.
Informational use only. Not financial advice.